{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-10-09",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "product_ndc": "76420-867",
      "generic_name": "Naloxone Hydrochloride",
      "labeler_name": "Asclemed USA, Inc.",
      "brand_name": "Naloxone Hydrochloride",
      "active_ingredients": [
        {
          "name": "NALOXONE HYDROCHLORIDE",
          "strength": "4 mg/.1mL"
        }
      ],
      "finished": true,
      "packaging": [
        {
          "package_ndc": "76420-867-02",
          "description": "2 BLISTER PACK in 1 CARTON (76420-867-02)  / 1 VIAL, SINGLE-DOSE in 1 BLISTER PACK / .1 mL in 1 VIAL, SINGLE-DOSE",
          "marketing_start_date": "20241029",
          "sample": false
        }
      ],
      "listing_expiration_date": "20261231",
      "openfda": {
        "manufacturer_name": [
          "Asclemed USA, Inc."
        ],
        "rxcui": [
          "1725059"
        ],
        "spl_set_id": [
          "7acf3bde-f858-4fbc-8a11-6741a3d27b8e"
        ],
        "unii": [
          "F850569PQR"
        ]
      },
      "marketing_category": "ANDA",
      "dosage_form": "SPRAY, METERED",
      "spl_id": "259ab241-9f39-0383-e063-6394a90a040c",
      "product_type": "HUMAN OTC DRUG",
      "route": [
        "NASAL"
      ],
      "marketing_start_date": "20240923",
      "product_id": "76420-867_259ab241-9f39-0383-e063-6394a90a040c",
      "application_number": "ANDA209522",
      "brand_name_base": "Naloxone Hydrochloride",
      "pharm_class": [
        "Opioid Antagonist [EPC]",
        "Opioid Antagonists [MoA]"
      ]
    }
  ]
}